跳转至内容
Merck
CN

D39800

Sigma-Aldrich

1,10-二溴癸烷

97%

别名:

溴化十次甲基

登录查看公司和协议定价


About This Item

线性分子式:
Br(CH2)10Br
CAS号:
分子量:
300.07
Beilstein:
506156
EC 号:
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
NACRES:
NA.22

质量水平

方案

97%

表单

crystals

折射率

n20/D 1.4912 (lit.)

沸点

160 °C/15 mmHg (lit.)

mp

25-27 °C (lit.)

密度

1.335 g/mL at 25 °C (lit.)

SMILES字符串

BrCCCCCCCCCCBr

InChI

1S/C10H20Br2/c11-9-7-5-3-1-2-4-6-8-10-12/h1-10H2

InChI key

GTQHJCOHNAFHRE-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

1,10-二溴癸烷,又称二溴代十亚甲基,一种芳香族和脂肪族单体,常用于聚合反应合成高分子量聚硫化物(缩聚反应)。

应用

1,10-二溴癸烷用于:
  • 在聚乙烯合成中用作Wurtz-type反应的反应物

  • 柱状[4]芳烃[1]醌-1,10-二溴癸烷假环紫杉烷在溶液和固体中的构造。:这项研究突出了1,10-二溴癸烷在构建复杂分子结构称为假环紫杉烷的应用。该研究重点关注这些结构在溶液和固体状态下的合成和稳定,为化学工程、药物合成和工业化学制造领域的高性能材料的开发提供了基础技术。这一突破为基于这些超分子组件的独特性质的新型药物输送系统和智能材料提供了潜在的途径(Sheng et al., 2020)。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

233.6 °F - closed cup

闪点(°C)

112 °C - closed cup

个人防护装备

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Design and Synthesis of Imidazolium-Mediated Tro?ger?s Base-Containing Ionene Polymers for Advanced CO2 Separation Membranes
Irshad k, et al.
ACS Omega, 4, 3439-3448 (2019)
Chemical structures, properties, and applications of selected crude oil-based and bio-based polymers
Piotr K, et al.
Polymers, 14, 5551-5551 (2022)
Synthesis of polysulfides containing s-triazine rings from 6-substituted amino-1, 3, 5-triazine-2, 4-dithiols and 1, 10-dibromodecane
Yoshiyuki O, et al.
Macromolecular Rapid Communications, 20, 294-298 (1999)
Stefania Aivali et al.
The journal of physical chemistry. B, 124(24), 5079-5090 (2020-05-28)
Conjugation-break flexible spacers in-between π-conjugated segments were utilized herein toward processable perylene diimide (PDI)-based polymers. Aromatic-aliphatic PDI-based polymers were developed via the two-phase polyetherification of a phenol-difunctional PDI monomer and aliphatic dibromides. These polyethers showed excellent solubility and film-forming ability
Ruili Zhang et al.
Advanced healthcare materials, 9(14), e2000394-e2000394 (2020-06-17)
The complexity of biological systems poses a great challenge in the development of nanotheranostic agents with enhanced therapeutic efficacies. To systematically overcome a series of barriers during in vivo administration and achieve optimal antitumor activity, nanotheranostic agents that can self-adaptively

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持